Form 4: Century Therapeutics' Chief Operations Officer Executes Stock Options and Sells Shares

Adrienne Farid, Chief Operations Officer of Century Therapeutics, exercised stock options and sold shares of common stock on March 6th and 7th, 2024, under a pre-arranged trading plan.

Summary

• Adrienne Farid, the Chief Operations Officer of Century Therapeutics, executed stock options to acquire common stock and subsequently sold a portion of those shares.
• The transactions occurred on March 6th and 7th, 2024.
• On March 6th, 30,684 shares were acquired at $1.03 per share and sold at a weighted average price of $4.9648, with prices ranging from $4.85 to $5.07.
• On March 7th, 22,831 shares were acquired at $1.03 per share and sold at a weighted average price of $5.1396, with prices ranging from $4.87 to $5.48.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on November 17, 2022.
• Following these transactions, Farid directly owns 114,149 shares of common stock and holds options to purchase 168,655 shares.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The Rule 10b5-1 trading plan is a common tool used by insiders to avoid accusations of trading on non-public information, aligning with best practices in corporate governance.
• Comparable companies such as CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics also have executives who file Form 4s regularly.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, depending on the volume and market perception.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates